Connection

Susan Dorman to Adult

Back to Details
This is a "connection" page, showing publications Susan Dorman has written about Adult.
Susan Dorman
Connection Strength
1.358
Adult
  1. Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion. BMC Infect Dis. 2022 Mar 12; 22(1):246.
    View in: PubMed
    Score: 0.057
  2. Latent Tuberculosis Infection. N Engl J Med. 2021 12 09; 385(24):2271-2280.
    View in: PubMed
    Score: 0.056
  3. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
    View in: PubMed
    Score: 0.054
  4. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. Contemp Clin Trials. 2020 03; 90:105938.
    View in: PubMed
    Score: 0.049
  5. Transmission of Mycobacterium tuberculosis From Patients Who Are Nucleic Acid Amplification Test Negative. Clin Infect Dis. 2018 11 13; 67(11):1653-1659.
    View in: PubMed
    Score: 0.045
  6. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018 01; 18(1):76-84.
    View in: PubMed
    Score: 0.042
  7. A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. PLoS One. 2016; 11(5):e0154778.
    View in: PubMed
    Score: 0.038
  8. Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis. J Clin Microbiol. 2016 Apr; 54(4):1051-7.
    View in: PubMed
    Score: 0.037
  9. Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2015 Jul; 19(7):780-6.
    View in: PubMed
    Score: 0.036
  10. Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial. Am J Respir Crit Care Med. 2015 Feb 01; 191(3):333-43.
    View in: PubMed
    Score: 0.035
  11. Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda. PLoS One. 2014; 9(7):e101459.
    View in: PubMed
    Score: 0.033
  12. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J Acquir Immune Defic Syndr. 2014 Jul 01; 66(3):270-9.
    View in: PubMed
    Score: 0.033
  13. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. AIDS. 2014 Jun 01; 28(9):1307-14.
    View in: PubMed
    Score: 0.033
  14. Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis. J Clin Microbiol. 2014 Jul; 52(7):2513-20.
    View in: PubMed
    Score: 0.033
  15. Interferon-? release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014 Jan 01; 189(1):77-87.
    View in: PubMed
    Score: 0.032
  16. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda. AIDS. 2013 Nov 28; 27(18):2883-92.
    View in: PubMed
    Score: 0.032
  17. Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey. PLoS One. 2012; 7(8):e43307.
    View in: PubMed
    Score: 0.029
  18. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium. J Infect Dis. 2012 Oct 01; 206(7):1030-40.
    View in: PubMed
    Score: 0.029
  19. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS One. 2012; 7(5):e36551.
    View in: PubMed
    Score: 0.029
  20. Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers. Clin Pharmacol Ther. 2012 May; 91(5):881-8.
    View in: PubMed
    Score: 0.029
  21. Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J Clin Microbiol. 2012 Apr; 50(4):1189-94.
    View in: PubMed
    Score: 0.028
  22. Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study. PLoS One. 2011; 6(10):e26787.
    View in: PubMed
    Score: 0.028
  23. QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact. Int J Tuberc Lung Dis. 2011 May; 15(5):628-34.
    View in: PubMed
    Score: 0.027
  24. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Microbiol. 2010 Aug; 48(8):2972-4.
    View in: PubMed
    Score: 0.025
  25. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009 Aug 01; 180(3):273-80.
    View in: PubMed
    Score: 0.023
  26. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis. 2009 Feb 28; 9:23.
    View in: PubMed
    Score: 0.023
  27. Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations. Antimicrob Agents Chemother. 2008 Nov; 52(11):4037-42.
    View in: PubMed
    Score: 0.022
  28. Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study. BMC Public Health. 2008 May 12; 8:158.
    View in: PubMed
    Score: 0.022
  29. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis. 2007 Mar 01; 44(5):674-80.
    View in: PubMed
    Score: 0.020
  30. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Arch Intern Med. 2006 Sep 25; 166(17):1863-70.
    View in: PubMed
    Score: 0.019
  31. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS. 2006 Mar 21; 20(5):751-62.
    View in: PubMed
    Score: 0.019
  32. Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol. 2004 Jan; 11(1):94-7.
    View in: PubMed
    Score: 0.016
  33. Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection. Respir Med. 2023 01; 206:107069.
    View in: PubMed
    Score: 0.015
  34. Field evaluation of a rapid immunochromatographic test for tuberculosis. J Clin Microbiol. 2002 Jun; 40(6):1989-93.
    View in: PubMed
    Score: 0.014
  35. Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2021 09 17; 65(10):e0179420.
    View in: PubMed
    Score: 0.014
  36. Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis. J Antimicrob Chemother. 2021 02 11; 76(3):582-586.
    View in: PubMed
    Score: 0.013
  37. Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection. Am J Respir Crit Care Med. 2020 09 15; 202(6):866-877.
    View in: PubMed
    Score: 0.013
  38. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid. Clin Infect Dis. 2020 08 22; 71(5):1161-1167.
    View in: PubMed
    Score: 0.013
  39. Predictive value of TNF-a, IFN-?, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada. BMC Infect Dis. 2020 Jul 31; 20(1):553.
    View in: PubMed
    Score: 0.013
  40. Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial. Lancet HIV. 2020 01; 7(1):e27-e37.
    View in: PubMed
    Score: 0.012
  41. A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. Antimicrob Agents Chemother. 2019 04; 63(4).
    View in: PubMed
    Score: 0.012
  42. Adjunctive corticosteroid therapy for patients whose treatment for disseminated Mycobacterium avium complex infection has failed. Clin Infect Dis. 1998 Mar; 26(3):682-6.
    View in: PubMed
    Score: 0.011
  43. Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study. Int J Infect Dis. 2018 Mar; 68:44-49.
    View in: PubMed
    Score: 0.011
  44. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis. N Engl J Med. 2017 09 14; 377(11):1043-1054.
    View in: PubMed
    Score: 0.010
  45. Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials. Clin Pharmacol Ther. 2017 Aug; 102(2):321-331.
    View in: PubMed
    Score: 0.010
  46. Comparing TSPOT assay results between an Elispot reader and manual counts. Tuberculosis (Edinb). 2016 12; 101S:S92-S98.
    View in: PubMed
    Score: 0.010
  47. Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers. Tuberculosis (Edinb). 2016 12; 101S:S83-S91.
    View in: PubMed
    Score: 0.010
  48. Occupational Risk Factors for Tuberculosis Among Healthcare Workers in KwaZulu-Natal, South Africa. Clin Infect Dis. 2016 05 15; 62 Suppl 3:S255-61.
    View in: PubMed
    Score: 0.010
  49. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology. PLoS One. 2015; 10(7):e0133756.
    View in: PubMed
    Score: 0.009
  50. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers. Antimicrob Agents Chemother. 2015; 59(6):3399-405.
    View in: PubMed
    Score: 0.009
  51. Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial. Trials. 2015 Mar 28; 16:125.
    View in: PubMed
    Score: 0.009
  52. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. BMC Infect Dis. 2015 Feb 15; 15:62.
    View in: PubMed
    Score: 0.009
  53. Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation. J Clin Microbiol. 2015 Apr; 53(4):1258-63.
    View in: PubMed
    Score: 0.009
  54. Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda. PLoS One. 2014; 9(9):e107595.
    View in: PubMed
    Score: 0.008
  55. Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability. Antimicrob Agents Chemother. 2014 Jun; 58(6):3035-42.
    View in: PubMed
    Score: 0.008
  56. Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil. Int J Tuberc Lung Dis. 2013 Oct; 17(10):1336-40.
    View in: PubMed
    Score: 0.008
  57. The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis. 2013 Aug; 57(4):532-42.
    View in: PubMed
    Score: 0.008
  58. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. Int J Tuberc Lung Dis. 2013 Apr; 17(4):552-8.
    View in: PubMed
    Score: 0.008
  59. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study. PLoS One. 2012; 7(11):e49898.
    View in: PubMed
    Score: 0.007
  60. A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa. Int J Tuberc Lung Dis. 2012 Jan; 16(1):82-9.
    View in: PubMed
    Score: 0.007
  61. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. J Acquir Immune Defic Syndr. 2011 Oct 01; 58(2):219-23.
    View in: PubMed
    Score: 0.007
  62. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):145-51.
    View in: PubMed
    Score: 0.006
  63. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009 Apr; 80(4):634-9.
    View in: PubMed
    Score: 0.006
  64. The rapid development of fluoroquinolone resistance in M. tuberculosis. N Engl J Med. 2003 Nov 13; 349(20):1977-8.
    View in: PubMed
    Score: 0.004
  65. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis. 2003 Dec 01; 37(11):1448-52.
    View in: PubMed
    Score: 0.004
  66. Nocardia veterana as a pathogen in North American patients. J Clin Microbiol. 2003 Jun; 41(6):2560-8.
    View in: PubMed
    Score: 0.004
  67. Isolated intracranial infection with Mycobacterium avium complex. J Neurosurg Sci. 2003 Jun; 47(2):101-5; discussion 105.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.